Publication | Closed Access

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

VaccinationL1 Virus-like-particle VaccineVulvar DiseasesVaccine DevelopmentHuman Papillomavirus VaccinesHigh-grade VulvalGynecologyVirologyPolyvalent VaccineVaginal LesionsMedicineVaccine ResearchPrecancerous LesionsSexual And Reproductive HealthCancer-associated Virus